All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

What a 22kg Ozempic weight loss story gets right and wrong

Sharon van Wyk 🇿🇦

TikTok creator

63.9K viewsWatch on TikTok→

Quick answer

Sharon describes eating a high-protein, vegetable-forward diet with reduced alcohol while on semaglutide (Ozempic), crediting the combination with a 22kg weight loss. Her reported appetite suppression and absence of snacking are consistent with semaglutide's documented effects on gastric emptying and hypothalamic satiety signaling. The dietary pattern she follows broadly aligns with clinical recommendations for optimizing body composition outcomes during GLP-1 receptor agonist therapy, though protein intake targets and resistance training are not addressed in her account.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.

What did @sharonvanwyk3 actually say?

Sharon kept it refreshingly simple. She described a single day of eating on semaglutide (Ozempic) that she credits with a 22kg weight loss "so far." Breakfast was chia seeds soaked in Greek yogurt with collagen, low-carb granola, maple syrup, and blueberries. Lunch was an Asian slaw with rotisserie chicken. Dinner was spiced chicken off the braai with salad and a baked potato. She was clear that there is "no meal plan" and that she is "just following the basic principles of a balanced diet" with "no food exclusions" aside from cutting back significantly on alcohol. She also noted she generally does not snack because the medication blunts her hunger enough that she simply does not feel like eating more.

This is a personal account, not a prescription. She did not claim to be a dietitian, she did not push supplements aggressively, and she did not tell viewers to copy her plate. Credit where it is due: that framing is more responsible than most GLP-1 content on TikTok.

Does the science back this up?

Broadly, yes. The eating pattern she described, protein-forward, vegetable-heavy, moderate carbohydrate, reduced alcohol, no rigid exclusions, is consistent with what researchers recommend for people on GLP-1 receptor agonists. The weight loss figure of 22kg is plausible and sits within the range seen in clinical trials.

The STEP 1 trial (Wilding et al., 2021, New England Journal of Medicine) found that semaglutide 2.4mg weekly produced an average body weight reduction of about 14.9% over 68 weeks, which for many people translates to 15-20kg or more depending on starting weight. Sharon's 22kg loss is entirely within that range, though individual results vary considerably. The appetite suppression she describes, not feeling hungry enough to snack, is also well-documented. Semaglutide slows gastric emptying and acts on hypothalamic satiety pathways, which is why people on it often report eating substantially less without feeling deprived (Drucker, 2018, Cell Metabolism). Her protein and fiber choices would also help maintain muscle mass during caloric restriction, which is a legitimate concern on any significant weight loss program.

What did they get wrong (or right)?

She got the broad strokes right. The meal she described is genuinely balanced: Greek yogurt and chicken provide adequate protein, the vegetables in the slaw and salad supply fiber and micronutrients, and the baked potato is a reasonable whole-food carbohydrate source. The reduction in alcohol is also clinically sensible. Alcohol is calorie-dense, disrupts sleep and insulin sensitivity, and can interact poorly with nausea that some people experience on GLP-1 medications.

The collagen supplement is where things get a little wobbly. Collagen is popular, but the evidence that oral collagen supplementation meaningfully improves skin, joints, or body composition in otherwise healthy adults is thin and largely industry-funded (Shaw et al., 2017, British Journal of Nutrition). It is not harmful, but it is not the protein workhorse she might think it is. Dietary protein from whole foods like yogurt and chicken does the heavy lifting. The maple syrup addition is also worth a flag: it is a small amount and not a dealbreaker, but added sugars offer little nutritional value and can make blood sugar management harder, which matters more when you are on a medication that already affects gastric emptying.

What should you actually know?

Sharon's approach works for her, and the principles she is applying are sound. But a one-day food diary from one person on one dose of one medication tells you almost nothing about what you should eat. GLP-1 receptor agonists reduce appetite dramatically for most users, which means people can accidentally undereat protein and muscle loss becomes a real risk over months of use.

Research published by Bikou et al. (2023, Nutrients) and others has flagged that without deliberate protein prioritization, a meaningful portion of weight lost on semaglutide can come from lean mass, not just fat. The current clinical consensus leans toward at least 1.2g of protein per kilogram of body weight per day during GLP-1-assisted weight loss, combined with resistance training. Sharon's meals look protein-reasonable, but a single day of eating cannot confirm she is hitting that target consistently. Anyone starting or adjusting a GLP-1 medication should work with a registered dietitian and their prescribing clinician, not reverse-engineer a TikTok food diary.

  • GLP-1 medications require a prescription and medical supervision. They are not appropriate for everyone.
  • Individual weight loss results vary significantly based on dose, starting weight, diet quality, activity level, and adherence.
  • Alcohol reduction on GLP-1 therapy is supported by both metabolic and tolerability evidence.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

GLP-1 social video fact-checksCompounded SemaglutideProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Compounded Semaglutide access requires the right clinical path

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 9 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For What a 22kg Ozempic weight loss story gets right and wrong, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

Compounded Semaglutide is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

Compare providers, services and access requirements in the directory before contacting a suitable care team.

Claim path

Keep researching this semaglutide video claims cluster

Best for searchers comparing social semaglutide claims with GLP-1 eligibility, outcomes, and safety context.

Claim verdict

The useful answer behind this video

Claim being checked

Sharon describes eating a high-protein, vegetable-forward diet with reduced alcohol while on semaglutide (Ozempic), crediting the combination with a 22kg weight loss.

FormBlends verdict

Sharon describes eating a high-protein, vegetable-forward diet with reduced alcohol while on semaglutide (Ozempic), crediting the combination with a 22kg weight loss. Her reported appetite suppression and absence of snacking are consistent with semaglutide's documented effects on gastric emptying and hypothalamic satiety signaling. The dietary pattern she follows broadly aligns with clinical recommendations for optimizing body composition outcomes during GLP-1 receptor agonist therapy, though protein intake targets and resistance training are not addressed in her account.

Patient-safe next step

Compare the claim with the Compounded Semaglutide guide, safety notes, access rules, and a licensed-provider review.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • Sharon describes eating a high-protein, vegetable-forward diet with reduced alcohol while on semaglutide (Ozempic), crediting the combination with a 22kg weight loss. Her reported appetite suppression and absence of snacking are consistent with semaglutide's documented effects on gastric emptying and hypothalamic satiety signaling. The dietary pattern she follows broadly aligns with clinical recommendations for optimizing body composition outcomes during GLP-1 receptor agonist therapy, though protein intake targets and resistance training are not addressed in her account.
  • The STEP 1 trial (Wilding et al., 2021, NEJM) showed average weight loss of ~14.9% of body weight on semaglutide 2.4mg, making a 22kg loss biologically plausible but highly individual.
  • Semaglutide suppresses appetite via hypothalamic pathways and delayed gastric emptying, which explains why Sharon reports not feeling hungry enough to snack.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compounded Semaglutide decisions still need source quality, legal access, and provider oversight checks.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against the Compounded Semaglutide guide, cost path, safety notes, and provider review before acting.

Review Compounded Semaglutide

What You'll Learn

  • The STEP 1 trial (Wilding et al., 2021, NEJM) showed average weight loss of ~14.9% of body weight on semaglutide 2.4mg, making a 22kg loss biologically plausible but highly individual.
  • Semaglutide suppresses appetite via hypothalamic pathways and delayed gastric emptying, which explains why Sharon reports not feeling hungry enough to snack.
  • Research (Bikou et al., 2023, Nutrients) indicates that without deliberate protein prioritization, GLP-1-assisted weight loss can include significant lean muscle mass loss, not only fat.
  • Current clinical guidance suggests aiming for at least 1.2g of protein per kilogram of body weight daily during GLP-1 therapy, ideally combined with resistance training.
  • Reducing alcohol during semaglutide treatment is well-supported: it removes empty calories, supports insulin sensitivity, and may reduce gastrointestinal side effects.
  • Collagen supplements are widely used but the evidence for benefits beyond those from standard whole-food protein sources remains limited and often industry-funded (Shaw et al., 2017, British Journal of Nutrition).
  • A single-day food diary from one user at an unknown dose and stage of treatment is not a template. Anyone on or considering GLP-1 therapy should consult a prescribing clinician and a registered dietitian.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Sharon van Wyk 🇿🇦 · TikTok creator

63.9K views on this video

I thought I'd do a more "summary" edition of what I eat in a day on Ozempic that has resulted in my 22kg weight loss 𝑺𝑶 𝑭𝑨𝑹... Was this helpful? Let me know in the comments! #southafricatiktok🇿🇦 #southafricatiktok

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Sharon van Wyk 🇿🇦, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.